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1 Instituto Nacional de Saúde da Mulher da Criança e do Adolescente Fernandes Figueira–IFF/Fundação
Oswaldo Cruz–Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil, 2 Assistant Professor of Infectious Disease





To analyze adverse fetal and neonatal outcomes of Zika virus infection by the timing of
infection during pregnancy. Method: Cohort study of 190 pregnancies with 193 offspring
with a positive RT-PCR test for Zika virus (March/2016 to April/2017).
Results
Death or defects related to congenital Zika virus infection were identified in 37.3% of fetuses
and newborns, and microcephaly in 21.4% of the newborns. The proportion of small for ges-
tational age newborns was 21.9%. Maternal symptoms in the first trimester were signifi-
cantly associated with the birth of newborns with microcephaly/cerebral atrophy, small for
gestational age and with the deaths (one abortion, one stillbirth and the two neonatal
deaths). Maternal infection during the second trimester was further associated with asymp-
tomatic newborns at birth. The study showed that 58.5% of the offspring with microcephaly
and / or cortical atrophy were small for gestational age, with an evident decrease in symp-
tomatic offspring without microcephaly, 24.1%, and with only 9.1% in the asymptomatic
group.
Conclusion
This study showed that the earlier the symptoms appear during gestation, the more severe
the endpoints. We found a higher percentage of small for gestational age newborns
exposed to Zika virus early in gestation. We also found a group of apparently asymptomatic
newborns with proven Zika infection, which highlights the importance of follow up studies in
this population.
PLOS NEGLECTED TROPICAL DISEASES
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Author summary
Zika virus infected pregnant women brought many challenges for the public health system
because at the beginning of the outbreak there was no knowledge of the consequences of
this disease. Microcephaly became the more common and threatening finding related to
intrauterine Zika virus infection. Moreover, it was observed that there were others serious
consequences of this disease during pregnancy, which were a burden for mothers and
children. This study, following infected pregnant women, referred to our institution,
enabled the medical professional team to improve their expertise in dealing with this new
disease. Ours results showed a high frequency of intrauterine growth restriction, with
babies being born small. Besides, it was found that the more severe cases occurred in
women who were infected during the first trimester of gestation. Infections during the last
half of the gestation more frequently leaded to babies born without symptoms. However,
these results highlight the importance of following the babies born apparently
asssymptomatic.
Introduction
Congenital Zika virus (ZIKV) infections have the potential to severely affect fetal development
and can lead to a wide range of adverse pregnancy and neonatal outcomes, including sponta-
neous abortion, fetal loss, low birth weight, and congenital malformations, especially in the
central nervous system [1]. Despite some other studies involving pregnant women with con-
firmed ZIKV infection [2–6] gaps in knowledge are still found, especially regarding the broad
spectrum of perinatal involvement of congenital ZIKV infection, ranging from apparently
asymptomatic newborns to fetal and neonatal death.
Although the different methods used in the evaluation and classification of the newborn
may have contributed to the differing risk estimates, it remains uncertain whether other bio-
logical or environmental co-factors could contribute to the observed heterogeneity [7]. Several
studies to date have provided evidence that higher risks of adverse outcomes are associated
with early, as compared to later, ZIKV infections during pregnancy [2,4,5].
Based on these findings, we hypothesized that earlier maternal infections may cause more
deleterious embryonic or fetal compromise and, therefore, more severe repercussions for pre-
natal development. Thus, this study aimed to evaluate the adverse fetal and neonatal endpoints
due to ZIKV congenital infection by timing of viral infection during gestation and to describe
the range of abnormalities observed among the children with Congenital Zika Syndrome.
Materials and methods
Ethics statement
The study followed regulatory standards and guidelines established under Resolution N˚ 466/
2012 of the National Health Council and demands from the IFF Research Ethics Committee.
The subscribed number at CAAE 526756616000005269 referred to the Project “Vertical Expo-
sure to Zika Virus and Its Consequences for Child Neurodevelopment” and registered in Clin-
ical Trials.gov Identifier: NCT03255369. Written consent forms were obtained from the
pregnant women before inclusion in the study.
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Study design
A cross sectional study was performed in a cohort of pregnant women exposed to ZIKV infec-
tion analyzing the perinatal repercussions in pregnancy considering the trimester of exposition
(NCT03255369).
Study site. The study was conducted at the Obstetrics and Neonatology Services of the
Fernandes Figueira National Institute of Women, Children and Adolescent Health/Oswaldo
Cruz Foundation (IFF/FIOCRUZ), a public tertiary hospital located in Rio de Janeiro, Brazil.
This hospital is a reference center for congenital malformations and has provided specialized
care for the ZIKV-infected women and their children in the city of Rio de Janeiro since the
onset of 2015–2017 epidemic.
Population
The study population was recruited from a convenience sample of 194 pregnant women who
were referred by public and private healthcare services after laboratory diagnosis, clinical
symptoms, or evidence of fetal alteration during gestational ultrasound suggestive of ZIKV
infection.
Pregnant women with acute febrile syndrome, cutaneous rash or fetal ultrasound with mal-
formations suspected for Zika syndrome who tested positive by RT-PCR (urine or blood) were
included in the study, as well newborn infants with some suspected malformations related do
ZIKV who tested positive by RT-PCR.
Exclusion criteria
The exclusion criteria were specific situations found in the study’s population unrelated to
ZIKV congenital infection. One case of type II Arnold Chiari was excluded, as there was no
certainty if the ZIKV infection occurred before or after the diagnostic of the malformation.
Newborns with chromosomic alterations detected during fetal life by amniocentesis or at
birth, were excluded from the original cohort. Also, all fetuses and newborns with laboratory-
confirmed congenital infection by other TORCH [8] group agents were excluded at the admis-
sion in the original cohort.
Exposure
The primary exposure was the trimester of the proven maternal ZIKV infection. Gestational
trimesters were defined as: first trimester: up to 13 weeks and 6 days; second trimester: from
14 to 27 weeks and 6 days; and third trimester: after 28 weeks and until 40 weeks and 6 days
[9]. The timing of maternal infection during gestation was based on the reporting of the first
signs and symptoms suggestive of ZIKV infection, as per the manifestations described by the
Brazilian Ministry of Health [10], with the typical rash from the disease appearing as one of the
most striking signs.
Variables
The analysis evaluated both maternal, perinatal, anthropometric, and clinical variables. The
maternal variables were related to both socioeconomic conditions and gestational information,
such as the numbers of pregnancies and prior spontaneous abortions, maternal hypertensive
diseases, premature labor, and premature rupture of membranes. The perinatal variables
included the date of birth, date of fetal or neonatal death, delivery type (i.e., vaginal or C-sec-
tion), APGAR score (i.e., 1st and 5th minute), gestational age (i.e., as determined by last men-
strual period, obstetric ultrasound before 12 weeks and the newborn’s physical examination,
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New Ballard Score [11], in this order [12]). Gestational age was analyzed in whole weeks, with-
out specification of days, as recommended by the WHO [13]. The anthropometric variables
included birth weight (BW) in grams (g) and head circumference (HC) in centimeters (cm)
with the respective Z-scores to age and gender as per the InterGrowth21 neonatal growth
chart [14].
The clinical variables were related to examinations and evaluations of the newborns that
occurred after birth and up to 28 days of life, and included neuroimaging, ophthalmic, neuro-
logic, and orthopedic exams. Imaging exams included transfontanellar doppler ultrasound in
all newborns, cranial computed tomography scan and cranial magnetic resonance imaging
(MRIs) with or without contrast in cases of suspected alterations, with reports provided by
pediatric radiologists. The ophthalmic evaluations included indirect ophthalmoscopy con-
ducted by pediatric ophthalmologists with experience in congenital infection in the neonatal
population. Neurological evaluations were conducted by neuropediatricians and general clini-
cal evaluation by pediatric infectious disease specialists. Orthopedic evaluations were per-
formed by the pediatric orthopedics service when necessary following clinical referral.
Outcomes
The primary fetal and neonatal outcomes considered in this study were based on the previ-
ously stated patterns reported in other studies, and the most up-to-date information about
mother-to-child ZIKV infection [15]. All outcomes were defined when pregnancy ended or
within the first 28 days of life, regardless of gestational age.
The primary outcomes included:
1. Abortion defined as the expulsion or extraction of a product of the conception with less
than 500g and /or height less than 25 cm, or less than 22 weeks of gestation, with or without
evidence of life [16].
2. Fetal death (Stillbirth) defined as the death of the gestational product before expulsion or its
complete extraction from the mother’s body, regardless of pregnancy duration [16].
3. Neonatal death defined as a death occurring between 0 and 28 days of birth [17].
4. Small for gestational age (SGA) birth defined as a birth with birthweight below the 10th per-
centile (or Z score < minus 1.28) as per the InterGrowth 21neonatal growth chart [14]. We
have also considered the cutoff point of birth weight below the third percentile (or Z-
score< minus 1.88), as evidence of more severe intrauterine growth restriction, according
to the definition of Lee et al. (2003) [18].
5. Preterm birth defined as a birth with a gestational age of less than 37 weeks of pregnancy.
6. Symptomatic with microcephaly and/or cerebral atrophy defined as children with micro-
cephaly and/or cerebral atrophy identified through clinical and neuro-imaging evaluations.
Microcephaly was assessed in the first 24–48 hours of life and defined, respectively, as mod-
erate or severe with a HC of< minus 2 to minus 3 or of< minus 3 standard deviations
below the mean for sex and age as per the InterGrowth21 neonatal growth chart [19];
7. Symptomatic without microcephaly or cerebral atrophy defined as children with other
signs and symptoms consistent with congenital ZIKV infection as described by other
authors [15] and identified through the neuroimaging, ophthalmic, neurologic, and ortho-
pedic exams;
8. Asymptomatic defined as children with normal morphological and functional evaluations
within the first 28 days of life.
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Statistical analysis
The statistical analysis was performed with the program EPI-INFO version 7.2; all p-values
were calculated for 2-sided statistical tests using a 0.05 level of significance. Descriptive analysis
was conducted to estimate frequencies of adverse outcomes. Continuous variables were sum-
marized using mean and standard deviations or median and interquartile range, depending on
the distribution of the data and analysis of proportions to discrete or categorical variables. The
prevalence of adverse outcomes was estimated by the gestational period in which the viral
infection occurred. Chi-squared tests were used to compare proportions between categories;
Fisher’s exact tests were used for variables with cells including 5 or fewer observations.
Results
Of the 191 pregnancies, 194 offspring had positive RT-PCR results for ZIKV in any studied
biological material (Fig 1). After one exclusion, a newborn with Arnold Chiari Syndrome, the
total study population, which included three twin pregnancies, consisted of a total of 193
exposed fetuses and newborns.
Overall, the participating women had a mean age of 29.5 years (SD = 6.8), varying from 14
to 45 years. Most of these women had attained at least high school (63.1%), 55% self-reported
as white, and the average monthly Family income (Brazilian Reais) was 3,400 (SD = 3,840).
The primary perinatal data of the studied population are shown in Table 1. There were few co-
morbidities, such as maternal hypertension (13,3%) and gestational diabetes (3,9%). Among
the neonates, 69,8% were delivered by Caesarean section, and the majority (84.3%) were deliv-
ered at term with a mean gestational age of 38.2 weeks (Table 1).
Adverse fetal and neonatal outcomes were identified in 72 offsprings (37.3%) of the 193
exposed fetus, with one abortion and one stillbirth. There were four neonatal deaths until 28
days of life; in all four cases, the mothers had a viral infection in the first gestational trimester.
From the 193 exposed fetus, 70 (36.6%) presented with abnormalities upon examination and
121 offspring, representing 63.3%, were asymptomatic upon evaluation. Among the 70 symp-
tomatic neonates at birth, 41 had microcephaly and/or cerebral atrophy (58.6%), and 29 neo-
nates (41.4%) had other characteristics suggestive of ZIKV congenital disease, as described by
Moore et al [15], without microcephaly or cerebral atrophy. (Fig 2). Among the neonatal
deaths, three were born with evidence of microcephaly and/or cerebral atrophy and one only
presented with the characteristics of congenital ZIKV infection but without microcephaly. All
four neonatal deaths were considered small for gestational age, and one was delivered prema-
turely. Microcephaly in the full study population totaled 36 cases (18.7%), of which 27 cases
(14.1%) were classified as severe microcephaly.
Out of the 184 pregnancies with known period of maternal ZIKV symptoms, 64 (34.8%), 85
(46.2%), and 35 (19.0%) women reported the symptoms in the first, second, and third trimes-
ters of pregnancy, respectively. In nine cases, the mothers could not report the period of infec-
tion. The symptomatic newborns, with and without microcephaly, were exposed
predominantly in the first trimester, while those born asymptomatic were exposed mainly in
the second trimester (Table 2). Also, the SGA newborns were predominantly exposed in the
first trimester. In this population, 29 newborns were preterm (15.0%), of which 26 (89,6%)
were classified as moderate preterm (i.e., between 32 weeks and 36 weeks and 6 days of gesta-
tional age).There was no significant difference in the trimester of gestation exposition for pre-
mature birth (Table 2).
In the study population, 42 of 193 deliveries (21.9%) were SGA (i.e., less than the tenth per-
centile). There were 12 offspring who were both SGA and premature at delivery (i.e., 6.2% of
deliveries overall). The distribution of SGA cases also varied by the phenotype of liveborn
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neonates, with of 31/42 SGA cases (73.8%) exhibiting symptoms consistent with congenital
ZIKV infection (Fig 2). Considering a more restrictive cutoff point to define SGA, 38 (90.4%)
of the 42 SGA deliveries fell below the third percentile. In this sample, 58.5% of the cases classi-
fied in Group A (i.e., symptomatic with microcephaly/cerebral atrophy) and 24.1% classified
in Group B (i.e., symptomatic without microcephaly/cerebral atrophy) were SGA (Table 3).
Notably, there were 23 SGA under the third percentile in Group A.
Fig 1. Strobe Flowchart for selection of study subjects. There are three twin pregnancies in the sample.
https://doi.org/10.1371/journal.pntd.0008893.g001
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The clinical presentation of neonates with symptoms consistent with congenital ZIKV
infection were significantly associated with the first trimester of exposition to ZIKV. The most
severe abnormalities were predominantly related to the first trimester infection, although the
exposition in the second trimester was also associated with the impairment of fetus develop-
ment (Table 4). Microphtalmia and Coloboma were not related to the trimester of infection,
though the numbers of affected children were very small (Table 4).
Discussion
This study recruited the pregnant women during the outbreak of ZIKV infection which
occurred in Brazil between 2015–2017. This study showed that the earlier the symptoms
appear during gestation, the more severe the endpoints. About half of the patients complained
of viral infection signs and symptoms during the second trimester, which is in line with what it
was reported by Van Maldeghem K et al. [5] and França V A et al [20,1]. Within adverse preg-
nancy endpoints, neonates that were symptomatic with microcephaly/cerebral atrophy, small
for gestational age (SGA) and stillborn were more common in women that had symptoms ear-
lier during their pregnancy, which confirms data previously described (3–5) [21]. Microceph-
aly was present in 21.2% of the offsprings, which is significantly higher when compared to the
systematic review of Campos Coelho A. V. et al. (2017) [21], which reported a range from 1 to
13%, depending on location, to the 1% for French Polynesia [22] and to the 13% for the state
of Bahia [23]. However, our institution is a reference for malformations and received pregnant
women or newborn after birth with malformations and this can explain high rate of micro-
cephaly. Previous results from the same cohort in Rio de Janeiro, including only the pregnant
women with symptoms (fever and cutaneous rash) and positive RT-PCR results, published
recently, described only four cases of microcephaly (3.4%) (2). Once again, most microcephaly
cases were related to maternal viral infection during the first trimester, as occurred in our sam-
ple. Nonetheless, our high incidence of microcephaly could be explained because the hospital
is a referral center for congenital abnormalities during pregnancy. Our study showed no case
of microcephaly associated with maternal viral infection during the third trimester.
Table 1. Demographic and perinatal characteristics of the offspring (N = 193).
VARIABLE N MEAN (SD) N (%)
Multiple gestation 193 3 (1.5)
Maternal hypertension 181 24 (13.3)
Maternal diabetes 180 7 (3.9)
Maternal TORCH coinfection 193 6 (3.1)
Preterm birth 193 30 (15.5)
Male sex 191 95 (49.7)
Cesarean section 189 132 (69.8)
Gestational age at delivery (weeks) 193 38.2 (2.9)
HC at delivery (cm) 189 33.3 (3.2)
HC at delivery (Z-score) 189 0.17 (2.5)
Birthweight (g) 192 2976.14 (709.3)
TORCH—Toxoplasma gondii, others (Listeria monocytogenes, treponema pallidum, varicella-zoster virus, human
immunodeficiency virus, enterovirus and parvovirus B19), rubella virus, cytomegalovirus, and herpes simplex virus.
HC–head circumference.
The diferences in the sample number is due to missing values. There was one abortion from whom there weren’t
information on sex and anthropometry; and one stillbirth, accounting for the lack of information on sex.
https://doi.org/10.1371/journal.pntd.0008893.t001
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Our research found that 37.3% of pregnancies with exposition to ZIKV resulted in fetal or
neonatal adverse outcomes. In the literature, these proportions range from 5% [5] to 6% [4] in
two North American studies, 7% in French American territory (3), 55% in the French Guiana
[6]. A case control study in the Northeast of Brazil confirmed the association of microcephaly
with ZIKV exposure during gestation and refers 43% of association of cerebral abnormalities
with ZIKV infection in positive cases [24] The studies cited employed different methodologies,
related to the availability of imaging tests, selection of the exposed, and evaluation of the new-
borns, which can explain the variation of the percentages found, much lower than our study.
One of the explanations for this finding could be related to the more detailed investigation of
the newborns in our study, with more sophisticated imaging tests performed in every altered
Fig 2. Flowchart of study outcomes (N = 191a). a Excluding one miscarriage and one stillbirth. SGA- Small for gestational age (<10th
percentile according to the InterGrowth21 Neonatal growth chart); Preterm (<37 weeks of gestational age). SGA and preterm categories
are not mutually exclusive. Group A: Symptomatic with microcephaly and/or cerebral atrophy; Group B: Symptomatic without
microcephaly or cerebral atrophy; Group C: Asymptomatic.
https://doi.org/10.1371/journal.pntd.0008893.g002
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case, with cranial MRIs and CT scans, as well as multi-professional evaluation until 28 days of
age. Another explanation is that this was a reference hospital for ZIKV infection in pregnant
women and newborns, and also in fetal malformations in general.
The proportion of prematurity in this study was similar to the world percentage, about 11%
according to WHO [12], and 11.5% in Brazil according to Birth in Brazil research [25], as well
as in the population exposed to ZIKV: 13% in French Guiana [6] and 8.8% in New York City
[26]. Therefore, it could be assumed that mother-to-child ZIKV infection does not lead to
higher levels of premature births.
We found a higher percentage of small for gestational age newborns (21.9%) compared to
the Brazilian population and to other studies concerning the newborn population exposed to
ZIKV during gestation [3,26,27,28,29]. The study by Lee et al. (2013), including the population
of several underdeveloped and developing countries, reported a prevalence of 12.5% in Latin
America and the Caribbean [27], while in the population exposed to ZIKV, the proportions
ranged from 9% [2] to 13% [3], using the same definitions proposed by this study. The com-
parison of the prevalence of SGA newborns in Brazil is limited since national studies include
different profiles of hospital complexity, specific populations from each region and the use of
diverse methods for the classification of SGA newborns. In our study, the proportion of SGA
newborns was as significant as the more severe involvement of newborns, which is in agree-
ment with the study by Prata-Barbosa et al. [28]. The same trend occurred concerning the dis-
tribution throughout gestational trimesters: the earlier the maternal infection, the higher the
percentage of SGA newborns. Others studies with ZIKV-infected mothers, considering the
same definition for IUGR, reported a prevalence of SGA of 11.2% in Cooper et al [26], 12% in
Table 2. Relationship between the trimester of infection and the clinical outcomes (N = 182b).
GESTATIONAL TRIMESTER N (%)
OUTCOME N 1st 2nd 3rd p-valuea
GROUP A 35 29 (82.9) 6 (17.1) 0 <0.0001
GROUP B 28 13 (46.4) 10 (35.7) 5 (17.9) <0.0001
GROUP C 119 21 (17.6) 68 (57.1) 30 (25.2) <0.0001
SGA 38 21 (33.3) 15 (17.6) 2 (5.7) 0.003
Premature 28 10 (15.9) 13 (15.3) 5 (14.3) 0.978
a Pearson Chi Square was used to compare the distribution of the groups, the prevalence of SGA and the prevalence of premature in relation of the trimester of
gestation.
SGA- Small for gestational age (<10th percentile on InterGrowth21 Neonatal growth chart).
Group A: Symptomatic with microcephaly and/or cerebral atrophy; Group B: Symptomatic without microcephaly or cerebral atrophy; Group C: Asymptomatic.
b Exclusion from the analysis: nine cases with uncertain trimester of exposition, one abortion and one stillbirth in which the presence of microcephaly was not possible
to confirm.
https://doi.org/10.1371/journal.pntd.0008893.t002








SGA < p10 24 (58.5) 7 (24.1) 11 (9.1) <0.0001
SGA < p3 23 (59.0) 5 (17.9) 10 (8.3) <0.0001
SGA-Small for gestational age, below the 10th (P10) and 3rd percentile (P3), respectively, on InterGrowth21 Neonatal growth chart.
Group A: Symptomatic with microcephaly and/or cerebral atrophy; Group B: Symptomatic without microcephaly or cerebral atrophy; Group C: Asymptomatic.
https://doi.org/10.1371/journal.pntd.0008893.t003
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French Guiana [6] and 18% in Walker CL et al. [29], who also found head and abdominal cir-
cumferences below the 10th percentile in the ultrasounds performed. Thus, it could be inferred
that symmetrical IUGR in fetal ultrasounds might be an early gestational marker of a newborn
probably vertically infected by ZIKV.
The referred population to this facility during the Zika epidemic originated from both pri-
vate and public services, which could justify the higher maternal income and education level of
the studied population.
The strengths and limitations of the study warrant consideration. The key strength of the
study is that affected newborns were evaluated through specialized clinical investigations and
accurate imaging tests of the central nervous system. Cranial CT scans and MRIs were made in
almost every affected neonate, which also contributed to the identification of a more signifi-
cant number of the alterations found. One limitation of this study was that the inclusion of
Table 4. Common anomalies associated with congenital Zika Virus infection in this sample of symptomatic offspring per trimester of gestation (N = 184).








Microcephaly 182 24 (38.1) 6 (7.1) 0 <0.0001
BRAIN ANOMALIES
Cerebral cortex thinning 171 27 (46.6) 6 (7.3) 0 <0.0001
Abnormal gyral patterns 171 26 (44.8) 6 (7.3) 0 <0.0001
Corpus callosum anomalies 171 8 (13.8) 5 (6.1) 0 0.05
Cerebellar hypoplasia 171 8 (13.8) 1 (1.2) 0 0.002
Decreased white matter 171 11 (20.4) 4 (4.9) 0 0.001
Ventriculomegaly 170 29 (37.9) 3 (3.7) 0 <0.0001
Subcortical calcification 171 32 (55.2) 5 (6.1) 0 <0.0001
MUSKULOSKELETAL ANOMALIES
Congenital clubfoot 179 3 (4.9) 0 0 0.052
Arthrogryposis 179 6 (9.8) 2 (2.4) 0 0.038
Hip dislocation 179 5 (8.2) 1 (1.2) 0 0.033
NEUROLOGICAL IMPAIRMENT
Motor disability 175 31 (53.4) 10 (12.0) 1 (2.9) <0.0001
Hypertonia 175 32 (55.2) 9 (10.8) 3 (8.8) <0.0001
Pyramidal syndrome 175 29 (50.0) 7 (8.4) 2 (5.9) <0.0001
Hyperexcitability 175 21 (36.2) 6 (7.2) 0 <0.0001
Epilepsy 175 27 (46.6) 6 (7.2) 0 <0.0001
Swallowing dysfunction 175 13 (22.4) 1 (1.2) 1 (2.9) <0.0001
OPHTALMOLOGICAL ANOMALIES
Microphthalmia 173 1 (1.8) 0 1 (2.9) 0.352
Coloboma 173 1 (1.8) 2 (2.4) 1 (2.9) 0.931
Chorioretinal atrophy 173 16 (28.1) 4 (4.9) 0 <0.0001
Pigment mottling 173 12 (21.1) 1 (1.2) 0 <0.0001
Optic nerve hypoplasia 173 15 (26.3) 2 (2.4) 0 0.0001
Pearson Chi Square test.
11 offsprings were excluded: 9 with uncertain period of infection during gestation and 2 fetal deaths (one miscarriage and one stillbirth due to the impossibility of
clinical investigation.
In 14 newborns there were muskuloskeleton anomalies. In 49 there were neurological abnormalities and 173 had an ophtalmological evaluation.
List of features modified from Moore et al–Characterizing the pattern of anomalies in Congenital Zika Syndrome for pediatric clinicians. JAMA Pediatric.2017;171
(3):288–295 (15).
https://doi.org/10.1371/journal.pntd.0008893.t004
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some women after the fetal ultrasound with mycrocephaly. These fetal outcomes were detected
during the routine ultrasound in asymptomatic women and they were included in the recruit-
ment process, when previous fetal development impairment could not be known for certain,
so possibly introducing a selection bias. However, this was a reference hospital for ZIKV infec-
tions in pregnant women during an epidemic, and they were referred because, although not
having symptoms of ZIKV infection, they were tested after a fetal ultrasound showing abnor-
malities, and they had a positive RT-PCR in any biological material. Another limitation was
the size of the sample, which did not allow us to evaluate the occurrence of SGA adjusting for
others causes, for example, maternal hypertension, as we had only 13.3% of them in this sam-
ple. We are also not describing a control group in this paper.
Conclusions
The study confirmed the already reported relationships in other papers, which is the earlier the
ZIKV infection during pregnancy, the more severe the fetal endpoints and, therefore, the
greater morbimortality in the affected subjects. The higher percentage of SGA newborns
found in this study deserves attention, not only for the adequate management of the affected
population during the epidemics, but also the investigation of its causal mechanisms. This
study also identified a group of neonates without microcephaly but who presented with other
anomalies, neurological or clinical, and furthermore, we also identified another group that
although having a proven exposition during pregnancy were born apparently normal. This is a
matter of concern, as one cannot predict if these babies will remain with a normal develop-
ment in future. A long-term longitudinal study must be considered to evaluate better the end-
points brought by this congenital infection, especially the asymptomatic newborns, which
could help the understanding of the long-term consequences of this infection in pregnant
women.
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11. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to
include extremely premature infants. J Pediatr. 1991; 119(3):417–23. https://doi.org/10.1016/s0022-
3476(05)82056-6 PMID: 1880657
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